Clinical Trial Update: Emtricitabine Plus Adefovir Dipivoxil for Naive Chinese HBV Related Cirrhosis Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial in naive Chinese patients with chronic hepatitis B-related cirrhosis is evaluating the combination of emtricitabine and adefovir dipivoxil; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Liver Cirrhosis
• Liver Fibrosis

Drugs mentioned

• Emtriva (emtricitabine)
• Hepsera (adefovir dipivoxil)

Snippet

Sponsor: Asian-Pacific Alliance of Liver Disease, Beijing | Conditions: Hepatitis B, Chronic, Fibrosis | Phase 4 | Status: UNKNOWN